- Home
- IFBD vs IMRN Comparison
IFBD vs IMRN Comparison
Compare IFBD & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- IMRN
- Stock Information
- Founded
- IFBD 2001
- IMRN 1994
- Country
- IFBD China
- IMRN Australia
- Employees
- IFBD N/A
- IMRN N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- IFBD Technology
- IMRN Health Care
- Exchange
- IFBD Nasdaq
- IMRN Nasdaq
- Market Cap
- IFBD 8.4M
- IMRN 9.2M
- IPO Year
- IFBD 2021
- IMRN N/A
- Fundamental
- Price
- IFBD $1.09
- IMRN $1.70
- Analyst Decision
- IFBD
- IMRN Strong Buy
- Analyst Count
- IFBD 0
- IMRN 1
- Target Price
- IFBD N/A
- IMRN $5.00
- AVG Volume (30 Days)
- IFBD 93.1K
- IMRN 53.5K
- Earning Date
- IFBD 01-01-0001
- IMRN 06-17-2025
- Dividend Yield
- IFBD N/A
- IMRN N/A
- EPS Growth
- IFBD N/A
- IMRN N/A
- EPS
- IFBD N/A
- IMRN N/A
- Revenue
- IFBD $1,437,848.00
- IMRN $4,048,286.00
- Revenue This Year
- IFBD N/A
- IMRN N/A
- Revenue Next Year
- IFBD N/A
- IMRN N/A
- P/E Ratio
- IFBD N/A
- IMRN N/A
- Revenue Growth
- IFBD 413.52
- IMRN 82.90
- 52 Week Low
- IFBD $0.89
- IMRN $1.50
- 52 Week High
- IFBD $3.87
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- IFBD 48.03
- IMRN 43.37
- Support Level
- IFBD $0.99
- IMRN $1.69
- Resistance Level
- IFBD $1.23
- IMRN $1.89
- Average True Range (ATR)
- IFBD 0.07
- IMRN 0.17
- MACD
- IFBD 0.01
- IMRN -0.01
- Stochastic Oscillator
- IFBD 42.37
- IMRN 34.06
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.